Immunological properties of FMDV-gP64 fusion proteins expressed on SF9 cell and baculovirus surfaces. (Q42043174)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Immunological properties of FMDV-gP64 fusion proteins expressed on SF9 cell and baculovirus surfaces (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Cecilia Tami

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Rosario Barbieri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Analía Berinstein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Elisa Carrillo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Oscar Taboga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

840-845

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

Antigen chimaeras of poliovirus as potential new vaccines

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Multiple presentation of foreign peptides on the surface of an RNA-free spherical bacteriophage capsid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Expression of an animal virus antigenic site on the surface of a plant virus particle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Hybrid Ty virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

HBV core particles as a carrier for B cell/T cell epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Hepatitis B virus core particles as epitope carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Mechanism of neutralization of budded Autographa californica nuclear polyhedrosis virus by a monoclonal antibody: Inhibition of entry by adsorptive endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Presentation of antigenic sites from foot-and-mouth disease virus on the surface of baculovirus and in the membrane of infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Enhancement of the immune response elicited with foot-and-mouth disease virus vaccines by an extract of the Mycobacterium sp. wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Reconstitution of immunosuppressed mice with mononuclear cells from donors sensitized to foot-and- mouth disease virus (FMDV)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Cloned Viral Protein Vaccine for Foot-and-Mouth Disease: Responses in Cattle and Swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Protection of swine against foot-and-mouth disease with viral capsid proteins expressed in heterologous systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

New approaches to vaccination against foot-and-mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Peptide vaccines based on enhanced immunogenicity of peptide epitopes presented with T-cell determinants or hepatitis B core protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Rotavirus particles function as immunological carriers for the delivery of peptides from infectious agents and endogenous proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.070

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.03.070

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542209%20AND%20SRC:MED&resulttype=core&format=json

release_2drpopg2lng6hex4w5mxeojoou

5 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2drpopg2lng6hex4w5mxeojoou

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference